For companies in the Ozempic-fueled weight-loss economy, it's survival of the fittest

  • 📰 latimes
  • ⏱ Reading Time:
  • 16 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 82%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

As powerful anti-obesity drugs become more widely available, companies are repositioning themselves with new products and services.

Before he began taking Mounjaro last summer, Nick Lovell was the weight-loss economy's ideal customer. He signed up for WeightWatchers and bought 'Dr. Atkins' Diet Revolution' to try the low-carb regimen. He joined his first gym in middle school and has belonged to half a dozen others since. He paid for personal trainers and boutique fitness classes and underwent bariatric surgery in 2008. And yet, his 5-foot-9-inch frame stubbornly held onto its 258 pounds.

We’re actually thrilled at what lies ahead.” With many GLP-1 users reporting muscle loss as a side effect, Atkins is pushing its line of high-protein bars and shakes, “a deliciously easy way to meet your protein requirements to help you maintain lean muscle mass and bone health while you’re losing weight.

 

コメントありがとうございます。コメントは審査後に公開されます。
このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 11. in JP

日本 最新ニュース, 日本 見出し